The effect of life-long thyroxine treatment and physical activity on bone mineral density in young adult women with congenital hypothyroidism

Journal of Pediatric Endocrinology and Metabolism

Volumn 19, Issue 12, 2006, Pages 1405-1412

  Kempers, Marlies J E ^a   Vulsma, T ^a   Wiedijk, B M ^a   de Vijlder, J J M ^a   van Eck Smit, B L F ^a   Verberne, H J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Bone mineral density; Congenital hypothyroidism; Thyroxine

Indexed keywords

THYROXINE;

ADULT; ARTICLE; BONE DENSITY; BONE MINERAL; CLINICAL ARTICLE; CONGENITAL HYPOTHYROIDISM; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; HUMAN; HYPOTHESIS; LONG TERM CARE; LUMBAR SPINE; MOTOR PERFORMANCE; PHYSICAL ACTIVITY; REFERENCE VALUE; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; THYROTROPIN BLOOD LEVEL;

EID: 33846005176     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2006.19.12.1405     Document Type: Article

References (24)

1. Bassett JHD, Williams GR. The molecular actions of thyroid hormone in bone. Trends Endocrinol Metab 2003; 14: 356-364.
2. Harvey CB, O'Shea PJ, Scott AJ, Robson H, Siebler T, Shalet SM, Smarut J, Chassande O, Williams GR. Molecular mechanisms of thyroid hormone effects on bone growth and function. Mol Genet Metab 2002; 75: 17-30.
3. Grant DJ, Mcmurdo MET, Mole PA, Paterson CR. Is previous hyperthyroidism still a risk factor for osteoporosis in postmenopausal women? Clin Endocrinol 1995; 43: 339-345.
4. Diamond T, Nery L, Hales I. A therapeutic dilemma - suppressive doses of thyroxine significantly reduce bone-mineral measurements in both premenopausal and postmenopausal women with thyroid-carcinoma. J Clin Endocrinol Metab 1991; 72: 1184-1188.
5. Roberts CGP, Ladenson PW. Hypothyroidism. Lancet 2004; 363: 793-803.
6. Kempers MJE, van Trotsenburg ASP, van Tijn DA, Bakker E, Wiedijk BM, Endert E, de Vijlder JJM, Vulsma T. Disturbance of the fetal thyroid hormone state has long-term consequences for treatment of thyroidal and central congenital hypothyroidism. J Clin Endocrinol Metab 2005; 90: 4094-4100.
7. Leger J, Ruiz JC, Guibourdenche J, Kindermans C, Garabedian M, Czernichow P. Bone mineral density and metabolism in children with congenital hypothyroidism after prolonged L-thyroxine therapy. Acta Paediatr 1997; 86: 704-710.
8. Koch SW, Brnjac L, Ehrlich RM, Qureshi R, Krishnan S. Bone mass in children with congenital hypothyroidism treated with thyroxine since birth. J Pediatr Endocrinol Metab 1996; 9: 59-62.
9. Salerno M, Lettiero T, Esposito-del Puente A, Eposito V, Capalbo D, Carpinelli A, Padula S, del Puente A. Effect of long-term L-thyroxine treatment on bone mineral density in young adults with congenital hypothyroidism. Eur J Endocrinol 2004; 151: 689-694.
10. Kooistra L, Laane C, Vulsma T, Schellekens JM, van der Meere JJ, Kalverboer AF. Motor and cognitive development in children with congenital hypothyroidism: a long-term evaluation of the effects of neonatal treatment. J Pediatr 1994; 124: 903-909.
11. Mein AL, Briffa NK, Dhaliwal SS, Price RI. Lifestyle influences on 9-year changes in BMD in young women. J Bone Miner Res 2004; 19: 1092-1098.
12. Vulsma T. Etiology and pathogenesis of congenital hypothyroidism. Evaluation and examination of patients detected by neonatal screening in The Netherlands. Ph,D. Thesis, University of Amsterdam, 1991.
13. Toublanc JE. Guidelines for neonatal screening programs for congenital hypothyroidism. Working Group for Neonatal Screening in Paediatric Endocrinology of the European Society for Paediatric Endocrinology. Acta Paediatr 1999; 88 (Suppl 432): 13-14.
14. Grootenhuis MA, Stam H, Destree-Vonk A, Heymans HSA, Last BF. Levensloop vragenlijst voor jongvolwassenen [Course of life questionnaire for young adults]. Gedrag Gezondheid 2003; 31: 350.
15. Henderson SE, Sugden DA. Movement Assessment Battery for Children: Manual. London: Psychological Corporation, 1992.
16. Smits-Engelsman BCM. Movement ABC; Nederlandse Handleiding [Dutch manual Movement ABC). Lisse: Swets & Zeitlinger, 1998.
17. Oerbeck B, Sundet K, Kase BF, Heyerdahl S. Congenital hypothyroidism: influence of disease severity and L-thyroxine treatment on intellectual, motor, and school-associated outcomes in young adults. Pediatrics 2003; 112: 923-930.
18. Salerno M, Micillo M, Di Maio S, Capalbo D, Ferri P, Lettiero T, Tenore A. Longitudinal growth, sexual maturation and final height in patients with congenital hypothyroidism detected by neonatal screening. Eur J Endocrinol 2001; 145: 377-383.
19. Krolner B, Jorgensen SP. Spinal bone mineral content in myxoedema and thyrotoxicosis; effects of thyroid hormone(s) and antithyroid treatment. Clin Endocrinol 1983; 18: 439-446.
20. Langdahl BL, Loft AG, Eriksen EF, Mosekilde L, Charles P. Bone mass, bone turnover and body composition in former hypothyroid patients receiving replacement therapy. Eur J Endocrinol 1996; 134: 702-709.
21. Taelman P, Kaufman JM, Janssens X, Vandecauter H, Vermeulen A. Reduced forearm bone mineral content and biochemical evidence of increase bone turnover in women with euthyroid goitre treated with thyroid hormone. Clin Endocrinol 1990; 33: 107-117.
22. Franklyn JA, Betteridge J, Daykin J, Holder R, Oates GD, Parle JV, Lilley J, Heath DA, Sheppard MC. Long-term thyroxine treatment and bone mineral density. Lancet 1992; 340: 9-13.
23. 3 following thyroxine supplementation in congenital hypothyroidism. Clin Endocrinol 2002; 57: 529-537.
24. Abe E, Marians RC, Yu WQ, Wu XB, Ando T, Li YN, Iqbal J, Eldeiry L, Rajendren G, Blair HC, Davies TF, Zaidi M. TSH is a negative regulator of skeletal remodeling. Cell 2003; 115: 151-162.